HARBOR INVESTMENT ADVISORY, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1468792 LUTHERVILLE, MD

Position in HALO

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$116,935

+$116,726 QoQ

Shares Held

1,494

+37250.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#108

of 154 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR INVESTMENT ADVISORY, LLC holds $5,602,456 across 30 Biotechnology names. HALO ranks #7 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,382	$1,485,272
2	ARGX	Argenx SE	1,157	$1,073,429
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,399	$694,925
4	TECH	BIO-TECHNE Corp	9,300	$657,045
5	BBIO	BridgeBio Pharma, Inc.	1,835	$136,670
6	CRSP	CRISPR Therapeutics AG	2,300	$125,442
7	HALO	Halozyme Therapeutics, Inc. This page	1,494	$116,935
8	MDGL	Madrigal Pharmaceuticals, Inc.	208	$111,685

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$116,935	1,494	+37250.0%	Shares	Sole	2026-07-07
2024-06-30	$209	4	-99.8%	Shares	Sole	2024-07-19
2023-06-30	$67,414	1,869	0.0%	Shares	Sole	2023-07-14
2023-03-31	$71,377	1,869	+9.8%	Shares	Sole	2023-04-21
2022-12-31	$96,843	1,702	0.0%	Shares	Sole	2023-01-24
2022-09-30	$67,297	1,702	0.0%	Shares	Sole	2022-11-01
2022-06-30	$74,888	1,702	0.0%	Shares	Sole	2022-07-18
2022-03-31	$67,875	1,702	-12.9%	Shares	Sole	2022-04-20
2021-12-31	$78,570	1,954	0.0%	Shares	Sole	2022-01-10
2021-09-30	$79,488	1,954	0.0%	Shares	Sole	2021-10-12
2021-06-30	$88,731	1,954	+11.3%	Shares	Sole	2021-07-27
2021-03-31	$73,207	1,756	0.0%	Shares	Sole	2021-04-16
2020-12-31	$74,998	1,756	+58.8%	Shares	Sole	2021-02-04
2020-09-30	$29,065	1,106	—	Shares	Sole	2020-10-23
No filing history on record for this holder in this stock.